News and blogs
25 results found.
CAR-T treatment turned down on NHS
The NHS medicines watchdog has recommended that a treatment called Kymriah should not be available to people with diffuse large B-cell lymphoma (DLBCL).
Blood cancer patients may be denied CAR-T
Draft guidance by the NHS medicines watchdog recommends a new treatment that harnesses the immune system to fight cancer should not be available.
Blood cancer research breakthroughs
We look back on some of the biggest developments in blood cancer research that have led to improved NHScare for people with blood cancer.
Chimeric antigen receptor T-cell therapy (CAR-T) could be made available on the NHS
Chimeric antigen receptor T-cell therapy (CAR-T) could be made available on the NHS this year.
British Society for Haematology Annual Meeting 2018 highlights
I spent 3 days at the British Society for Haematology Annual Meeting in Liverpool with Blood Cancer UK research team. Read about some exciting studies.